ArticleCells2022

Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes.

Aleksandra Skalska-Bugala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.